Related Experiment Video
Updated: Aug 12, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Multiple testing of noninferiority hypotheses in active controlled trials
H M James Hung1, Sue-Jane Wang
1Division of Biometrics I, Food and Drug Administration, Rockville, Maryland 20852, USA. hung@cder.fda.gov
Prespecifying the maximum noninferiority margin allows valid statistical testing for multiple hypotheses at the same alpha level. This approach avoids multiplicity issues and ensures robust noninferiority trial analysis.
Area of Science:
- Biostatistics
- Clinical Trials
Background:
- Noninferiority trials aim to demonstrate that a new treatment is not unacceptably worse than a standard treatment.
- Statistical methods are crucial for establishing noninferiority while managing potential biases and multiplicity.
Purpose of the Study:
- To outline a valid statistical approach for multiple noninferiority hypotheses when a maximum noninferiority margin is prespecified.
- To address the complexities of multiplicity when using different confidence intervals for superiority and noninferiority testing.
Main Methods:
- Utilizing a single, prespecified maximum noninferiority margin for hypothesis testing.
- Performing statistical testing at a consistent alpha level across multiple noninferiority hypotheses.
- Highlighting the importance of fixing margin elements in advance, independent of trial data analysis.
Main Results:
- Valid statistical testing is achievable for multiple noninferiority hypotheses using a single alpha level when the maximum margin is prespecified.
- Using different confidence intervals (e.g., intent-to-treat vs. per-protocol) can introduce multiplicity issues requiring alpha adjustment.
- Pre-specifying margin elements prevents data-driven influence, ensuring the integrity of noninferiority analysis.
Conclusions:
- A prespecified maximum noninferiority margin simplifies multiple hypothesis testing and maintains statistical validity.
- Careful consideration of confidence intervals and pre-specification of margins are essential for robust noninferiority trial design and analysis.
- Adherence to pre-specified parameters is critical to avoid invalidating noninferiority trial results.
More Related Videos
06:28E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Related Concept Videos
Null and Alternative Hypotheses
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the population that is...
Types of Hypothesis Testing
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p ≠ 0.5.
Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Controls in Experiments
Bonferroni Test
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...